Docetaxel Injection IP

Name: Docetaxel Injection IP
Brand: NEETCO BIOPHARMA
Price: 1300 INR
Availability: InStock

Price 1300 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

Docetaxel Injection IP Specification

Indication
Breast cancer, Non-small cell lung cancer, Prostate cancer, Gastric cancer, Head and neck cancer

Dosage Form
Injection

Origin of Medicine
Allopathic

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
Docetaxel Trihydrate

Drug Type
Prescription

Ingredients
Docetaxel Trihydrate

Physical Form
Liquid

Function
Antineoplastic

Recommended For
Anti-cancer therapy

Dosage
As directed by oncologist

Dosage Guidelines
Intravenous infusion only under medical supervision

Suitable For
Adults

Quantity
80 mg / 2 ml

Storage Instructions
Store below 25C, protect from light

Prescription Status
Prescription only

Contraindications
Hypersensitivity to docetaxel or polysorbate 80; low neutrophil counts

Precautions
Monitor blood counts, liver, and renal function during therapy

Product Category
Anticancer Injectable

Brand Name
Docetaxel Injection IP

Strength
80 mg per 2 ml vial

Marketed By
Manufactured and marketed by reputed pharmaceutical companies in India

Color
Clear to pale yellow solution

Common Side Effects
Neutropenia, anemia, fatigue, nausea, hair loss, muscular pain

Reconstitution
Ready to use, does not require reconstitution

Presentation
Glass vial with flip-off cap, sterile-packed

Shelf Life
24 Months

Molecular Formula
C43H53NO14

Regulatory Approval
IP (Indian Pharmacopoeia) standard

Method of Administration
IV (Intravenous) infusion

Manufacturer's Instructions
For single use only, discard unused solution

About Docetaxel Injection IP

Experience the spotlight-worthy performance of Docetaxel Injection IP 80 mg/2 ml, an elite anticancer masterpiece recognized by the Indian Pharmacopoeia. This sought-after intravenous infusion is a ready-to-use ace in cancer therapeutics, suitable for adults facing breast, prostate, gastric, and other malignancies. Precision-manufactured by reputed Indian pharmaceutical companies, its clear to pale yellow solution ensures both safety and efficacy. Provided in a sterile, single-use glass vial, this prescription-only formulation offers reliable storage, outstanding shelf stability, and high demand among healthcare professionals for robust anti-neoplastic therapy.

Surface of Application and Distinguished Features

Docetaxel Injection IP acts as a potent anticancer agent primarily on solid tumor surfaces in breast, prostate, gastric, lung, head, and neck cancers. Its application extends to both primary and metastatic conditions. Notably, the injectable solution stands out with its ready-to-use format, requiring no reconstitution, ensuring safe and swift administration. The product is presented in secure glass vials with a flip-off cap and delivers consistent dosing, making it a dependable choice for elite cancer management strategies.

Payment Terms and Delivery Estimates

Docetaxel Injection IP is readily available for distributors, exporters, suppliers, and traders throughout India. Payment terms are flexible, making transactions smooth and reliable. Orders are handled with professional care and are typically delivered via the designated FOB ports within the estimated schedule provided at purchase. Each vial is securely packed and handed over to trusted couriers for safe delivery, ensuring compliance with temperature and light protection requirements, ready for prompt medical use across the main domestic market.

FAQ's of Docetaxel Injection IP:

Q: How should Docetaxel Injection IP be administered for optimal efficacy?

A: Docetaxel Injection IP must be given as an intravenous infusion under the direct supervision of an oncologist or medical professional, with dosage and schedule tailored to individual patient conditions.

Q: What cancers is Docetaxel Injection IP indicated for?

A: This injection is indicated for adults with breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancers, offering broad-spectrum antineoplastic relief.

Q: When should Docetaxel Injection IP not be used?

A: Docetaxel Injection IP is contraindicated in patients with known hypersensitivity to docetaxel or polysorbate 80, or those with critically low neutrophil counts.

Q: Where should Docetaxel Injection IP be stored before use?

A: The vials should be stored below 25C and protected from light to maintain their stability and effectiveness throughout their 24-month shelf life.

Q: What precautions should be taken during Docetaxel Injection IP therapy?

A: Routine monitoring of blood counts, liver, and renal function is necessary during therapy to manage potential side effects such as neutropenia, anemia, and fatigue.

Q: How is Docetaxel Injection IP presented and prepared for administration?

A: Each 80 mg/2 ml vial is presented in a sterile, single-use, glass vial with a flip-off cap. The solution is ready to use and does not require any reconstitution before intravenous administration.

Tell us about your requirement